Syneron Irons Out Some Wrinkles

Recs

1

Disney Buys Marvel!

David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT.

Stock Advisor

Syneron Medical (Nasdaq: ELOS) is hoping to smooth out the wrinkles in its growth with its latest offering. The aesthetic device maker's Matrix RF applicator, which is used to reduce facial wrinkles, was approved for use in the European Union Friday.

The Matrix RF applicator is an add-on that works with the company's eLight, eLaser, and eMax systems. Through radio frequencies -- that's what the RF stands for -- the device damages the layers under the skin, shrinks the collagen and promotes the generation of new collagen to smooth out the wrinkles. Unlike pure laser-based applications, the device doesn't damage the outer skin as much, leading to a quicker recovery.

Perhaps most importantly for Syneron, the Matrix RF has a disposable treatment tip. That'll supply a recurring revenue stream -- think Gillette razor blades -- something that the company has desperately needed. Syneron has also set up a "subscription" service for at least one of its fairly expensive machines, but the program isn't likely to bring in recurring revenue. It's more like an interest-free loan than a subscription because the price of the subscription can be used toward the purchase of the machine. I imagine most doctors will stay in the program just until they've paid enough to collect the machine.

The European approval for Matrix RF is probably more important than U.S. approval, given the growth Syneron has experienced overseas lately, though at least some of that was because of currency changes. In Europe, the market for its devices extends beyond doctors to other "aesthetic professionals," making for easier sales.

Syneron and other aesthetic device makers -- Palomar Medical (Nasdaq: PMTI), Cutera (Nasdaq: CUTR), and Cynosure (Nasdaq: CYNO) -- have been beaten down pretty well over the past year as discretionary spending has scaled back. The aesthetics market isn't likely to regain momentum until that turns around, but it looks like Syneron is setting itself up for success once it does.

More Foolishness on turnaround possibilities:

“The Next Great Investment”… That’s how a top global investor describes India’s potential. On Nov. 28, The Motley Fool’s Tim Hanson returns to India to prove it. Follow along in real time and get his TOP pick first (Hanson returned from China in July with a stock that’s up 169%!). Enter email below.

Syneron is a recommendation of Motley Fool Rule Breakers, which is always on the hunt for medical device and other cutting-edge picks. See all of this newsletter service's latest discoveries with a free 30-day trial. 

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. Syneron is also a Motley Fool Hidden Gems Pay Dirt selection. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 22, 2008, at 2:54 PM, marceloreddzinn wrote:

    Looking forward, also note that starting early next year, Syneron will be releasing its joint product with P&G which should provide some positive upside that is not reflected in the current price. Syneron has over $200M in Cash no Debt and continues to dominate the industry. The next year should be very good to Syneron given their current position and future prospects.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 733554, ~/Articles/ArticleHandler.aspx, 11/24/2009 6:10:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Why Investors Should Be Excited for a Bank Breakup

Related Tickers

11/23/2009 4:00 PM
CUTR $9.17 Up +0.09 +0.99%
Cutera, Inc. CAPS Rating: ****
CYNO $10.16 Up +0.10 +0.99%
Cynosure, Inc. CAPS Rating: *****
ELOS $10.27 Up +0.06 +0.59%
Syneron Medical Lt… CAPS Rating: *****
PMTI $9.21 Up +0.22 +2.45%
Palomar Medical Te… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Creative destruction: Creative destruction is the theory that suggest economies are strengthened by new companies that destroy or diminish existing companies.

Want to learn more or edit this definition?
Click here to read more!